Breaking News, Financial News

4Q Financial Reports: Millipore

Millipore

4Q Revenues: $256.3 million (+14%)

4Q Earnings: $1 million* (income was $24.8 million in 4Q2004)

YTD Revenues: $991 million (+12%)

YTD Earnings: $80.2 million (-24%)

Comments: In constant currency, quarterly revenue growth was 19%, led by 24% growth from the company’s Bioprocess division and 11% growth from its Bioscience division. Full year performance was led by 15% growth in the Bioprocess division and 7% growth in the Bioscience division.

*Includes a one-time tax expense of $30.6 million for the repatriation of foreign earnings and a tax benefit of $3.4 million from the reversal of tax valuation allowances. Fourth quarter results also included expenses of approximately $8.4 million relating to the company’s manufacturing consolidation strategy, amortization of acquired intangibles, and professional fees associated with the repatriation of foreign earnings.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters